Pulmonary embolism (PE) has often been considered a

Size: px
Start display at page:

Download "Pulmonary embolism (PE) has often been considered a"

Transcription

1 Prophylactic Inferior Vena Cava Filters: Do They Make a Difference in Trauma Patients? Robert A. Cherry, MD, FACS, Pamela A. Nichols, BSN, Theresa M. Snavely, BSN, RN, Mauger T. David, PhD, and Frank C. Lynch, MD Background: Inferior vena cava filters (IVCF) are used in trauma patients to reduce the incidence of pulmonary embolism (PE). This study investigates the efficacy of prophylactic IVCF (PIVCF) placement from implantation through outpatient follow-up. Methods: Data were prospectively collected on PIVCF placed in trauma patients >18-years old from 2004 to Exclusion criteria include therapeutic IVCF, major burns, deviated from a modified EAST protocol, and deaths. Data were collected on age, gender, Injury Severity Score (ISS), filter type, total implant days, PE, deep venous thrombosis (DVT), and filter-related complications. Statistical analysis: p < 0.05*, 2 square test, mean SD. Results: Of 4,936 patients, 280 had an IVCF with 244 meeting inclusion criteria. Study group demographics: 63.5% men; 98.8% blunt; mean age ; ISS There were 176 of 244 (72.1%) patients who met traditional EAST guidelines for PIVCF. PIVCF increased significantly from 29 in 2004 to 127 in 2006 with no difference in the PE rate (0.7% to 0.4%). There were 4 PEs (1.6%) on postprocedure days 7, 14, 18, and 23. Five technical complications occurred: two filter fractures, two caudal migrations, and one filter tilt. A total of 140 retrievable filters had the opportunity for outpatient follow-up for 18 months with 58.6% removed, 15.7% declared permanent, 12.1% lost to follow-up, and 13.6% still considered potential removal candidates. Days to implant: 0 to 32; Implant days: 15 to 838; mean Conclusions: PIVCF increased significantly without impacting the overall PE rate. There was a 1.6% PE rate among PIVCF, high retrieval rate (59%), low complication rate (0.1%), and satisfactory compliance with traditional EAST guidelines. Key Words: Wounds and injuries, Vena cava filters, Venous thrombosis, Pulmonary embolism. J Trauma. 2008;65: Pulmonary embolism (PE) has often been considered a potentially preventable complication in patients with multiple injuries. The incidence of PE in trauma patients has reportedly ranged from 1.0% to 23.4% 1 and is associated with serious morbidity and mortality. Prophylaxis with low dose unfractionated heparin (LDH), low-molecular weight heparin (LMWH), and sequential compression devices have been used to reduce the incidence of venous thromboembolism (VTE). However, there has been controversy regarding the efficacy of these methods of prophylaxis in the trauma literature. 2 Inferior vena cava filters (IVCF) have been used for many years as an adjunct in the prevention of pulmonary embolism (PE). The Eastern Association for the Surgery of Trauma (EAST) has published clinical guidelines on the prophylactic use of IVC filters. 3 The literature has been Submitted for publication December 14, Accepted for publication May 12, Copyright 2008 by Lippincott Williams & Wilkins From the Department of Surgery, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania. Presented as a poster at the 21st Annual Meeting of the Eastern Association for the Surgery of Trauma, January 15 19, 2008, Jacksonville, Florida. Address for reprints: Robert A. Cherry, MD, Section of Trauma and Critical Care, Department of Surgery, Penn State Milton S. Hershey Medical Center, 500 University Drive, Hershey, PA 17033; rcherry@psu.edu. DOI: /TA.0b013e31817f980f conflicting as to whether IVCF actually reduce the incidence of PE in trauma patients. 4 This is further compounded by the lack of class I literature on the subject and the varying definitions of the term prophylactic with respect to IVC filters. The efficacy of prophylactic IVCF must take into consideration several factors: (1) the ability to reduce the incidence of PE, (2) the complication rate related to IVCF insertion and dwelling time, and (3) the retrieval rate of removable filters. This study investigates the safety and efficacy of prophylactic IVCF (PIVCF) placement from this perspective, and examines prophylactic IVC filters from the day of implantation through outpatient follow-up. MATERIALS AND METHODS Selected data elements were prospectively collected on PIVCF that were placed in adult trauma patients 18-years old from January 2004 through December The trauma registry (Collector, Digital Innovation, Forest Hill, MD) was used during this same period of time to prospectively collect data on age, gender, blunt versus penetrating trauma, Injury Severity Score (ISS), Trauma and Injury Severity Score (TRISS), injury type, and the occurrence of PE and DVT. Prophylactic IVC filters were ordered by the trauma faculty using written clinical guidelines that were modified based on the EAST criteria (see Table 1). The distribution of injuries and the compliance rates for patients that met both traditional and modified EAST criteria for IVC filter placement were 544 September 2008

2 Prophylactic IVC Filters Table 1 Modified EAST Guidelines Who cannot receive anticoagulation because of increased bleeding risk, and have one or more of the following injury patterns: a. Severe closed head injury (GCS 8) b. Spinal cord injury with para or quadriplegia c. Spine fractures resulting in prolonged immobility ( 72 h)* d. Complex pelvic fractures with associated long-bone fractures e. Complex pelvic fractures without associated long-bone fractures* e. Multiple long-bone fractures f. High grade liver and spleen injuries managed non-operatively and unable to anticoagulate within 72 h* * Modified criteria. GCS indicates Glascow come scale. collected for comparison. The number of PIVCF was compared in each year for statistically significant differences, and whether or not these differences had an impact on the incidence of PEs. IVC filters were considered therapeutic if placed within 48 hours of the diagnosis of a PE. All PEs were identified using contrast-enhanced spiral CT performed either in evaluation of respiratory compromise or for other indications. Other variables collected included filter type, total implant days, and filter-related complications. Excluded from the study were patients who underwent insertion of a therapeutic IVC filter, had major burns, expired, or deviated from an institutional modification of the EAST protocol for PIVCF placement. We analyzed our outpatient IVC retrieval rate over an 18-month period following IVCF implantation, along with any procedural related complications. In the outpatient arena, the number of filters declared permanent, patients lost to follow-up, and potential candidates for filter removal were also monitored and recorded. All patients receiving PIVCF placement had contraindications to anticoagulation. This was analyzed at the discretion of the surgeon. Retrievable or retrievable IVC filters implanted during this time included the Bard G2, Bard Recovery, and Cook Gunther Tulip. Permanent filters that were implanted included the Braun Vena Tech LP, BSC Greenfield, Cook Bird s Nest, and Bard Simmon-Nitinol. The decision to place a retrievable versus a permanent filter was left to the discretion of the interventionalist performing the implantation. In general, patients under the age of 65 who were thought to have a high likelihood to recover from their injuries to an ambulatory state were deemed candidates for a retrievable filter. The interventional radiology service assumed primary responsibility for retrievable filter follow-up. Patients not referred for filter removal by trauma surgery within 90 days were contacted directly by the interventional radiology service when removal was deemed appropriate after a review of the patient record. Patients were deemed removal candidates if they had returned to an ambulatory state and/or they were therapeutically anticoagulated. Occasionally, patients were able to be safely anticoagulated late in their inpatient course, or as an outpatient, after implantation of a retrievable IVC filter. Patients not anticoagulated at the time of removal underwent venous duplex examination to exclude occult DVT. IVC filter removal was deferred or delayed if acute DVT was detected. Anticoagulation was not held for the procedure as long as the INR was less than tests were used for the statistical analysis. Mean and SD were reported as summary statistics for quantities with normal distributions. Statistical analyses were performed using SAS Version 9 (SAS Institute, Cary, NC). All p values 0.05 were used to denote significant differences between study groups. The study protocol was approved by the Institutional Review Board at the Penn State Milton S. Hershey Medical Center. RESULTS There were 280 IVC filters implanted during the study period. Of these, there were 16 therapeutic IVC filters, 11 deaths, 8 institutional protocol deviations, and 1 burn patient. All 36 of these patients were excluded from the study. The study group of 244 patients all underwent PIVCF. The group included 63.5% men, 37.5% women, and 98.8% blunt trauma patients with a mean age of , an ISS of , and a TRISS of There were 176 of 244 (72.1%) patients who met traditional EAST guidelines for PIVCF placement. The distribution of injuries meeting inclusion criteria among these 176 patients are shown on Table 2. The distribution of injuries for the 68 patients who met our modified EAST criteria is shown in Table 3. There was a statistically significant increase in the number of PIVC implanted between 2004 and 2006 (see Table 4). This was not associated a statistically significant change in the incidence of PE. The incidence of DVT in the study group was 9.0%. The DVT rate among those implanted with a PIVCF decreased from 24.1% in 2004 to 8.0% in 2005 and 6.3% in Despite the placement of a PIVCF, there were four PEs (1.6%) in the study group on postprocedure days 7, 14, 18, and 23. One of these patients had a documented DVT. The statistically significant increase in PIVCF placement was not associated with a difference in the PE rate (see Table 4). Table 2 Distribution of Injuries Among 176 Patients Meeting Traditional EAST Guidelines for PIVCF Injuries Long bone fracture 109 Pelvis fracture 99 TBI with GCS 8 93 Spine fractures 80 Spleen injury 39 Liver injury 31 SCI with paraplegia or quadriplegia 27 PIVCF indicates prophylactic inferior vena cava filter; TBI, traumatic brain injury; SCI, spinal cord injury; GCS, Glascow come scale. N Volume 65 Number 3 545

3 Table 3 Compliance With Traditional and Modified EAST Guidelines Patients meeting modified EAST Guidelines for 68 (27.9%) PIVCF* Complex fractures without long-bone fractures 53 Spine fractures with prolonged immobility 7 greater than 72 h High grade liver/unable to anticoagulate within 6 72 h High grade spleen/unable to anticoagulate 2 within 72 h Patients meeting traditional EAST Guidelines for 176 (72.1%) PIVCF Total 244 PIVCF indicates prophylactic inferior vena cava filter. *p 0.05 compared to Table 4 Prophylactic IVCF Implanted and Number of PEs Total Adult trauma patients 1,388 1,737 1,811 4,936 Prophylactic IVCF 29 (2.1) 88 (5.1)* 127 (7.0)* 244 (4.9) PEs 10 (0.7) 13 (0.7) 8 (0.4) 31 (0.6) Values in parentheses indicate percentage. IVCF indicates inferior vena cava filter; PE, pulmonary embolism. *p 0.05 compared to There were five filter-related technical complications (0.1%): two filter fractures (Bard Recovery), two caudal migrations (Bard G2), and one filter tilt (Bard G2). The total number of retrievable filters was 181 (74.8%). The days to implant ranged from 0 to 32 ( ) and the total number of implant days was 15 to 838 days ( ). The distribution in filter types were as follows: Bard G2 (n 116), Bard Recovery (n 64), and Cook Gunther Tulip (n 1). A total of 140 retrievable filters had the opportunity for outpatient follow-up for at least 18 months. The remaining 41 patients had filters placed after June of 2005 and therefore did not have the full opportunity Table 5 Outpatient IVCF Follow-Up Total filters removed 82 (58.6) Filters declared permanent 22 (15.7) Severe TBI or SCI 10 (7.2) IVC occlusion/thrombosis 3 (2.2) Failed filter removal 1 (0.7) Patient refusal 4 (2.8) Age and further surgery 2 (1.4) General debilitation 1 (0.7) Duration of implantation 1 (0.7) Lost to follow-up 17 (12.1) Potential removal candidate 19 (13.6) Total 140 Values in parentheses indicate percentage. IVCF indicates inferior vena cava filter; TBI, traumatic brain injury; SCI, spinal cord injury. for an 18-month follow-up period as part of the study protocol. Of the 140 retrievable filters with an 18-month followup, we found that 58.6% were removed, 15.7% were declared permanent, 12.1% were lost to follow, and 13.6% were still considered potential removal candidates (see Table 5). The majority of IVC filters that were removed occurred in the first year after implantation (77 of 82 or 93.9%). DISCUSSION Although our study demonstrated a statistically significant increase in PIVCF placement over a 3-year period, this was not associated with a decrease in our incidence in PEs. We initially adopted the EAST guidelines for PIVCF placement after our trauma center experienced an increase in the number of PEs in Several reports in the literature found a statistically significant decrease in the incidence of PE after the implementation of protocols for the use of prophylactic IVC filter placement. 5 7 We introduced modifications to the EAST protocol based on our performance improvement program. There was a statistically significant increase in the number of IVC filters implanted on the Trauma Service between 2004 and We did notice a reduction in our PE rate from 0.7% to 0.4%. However, despite the more aggressive use of prophylactic IVC filters, the decreased incidence of PEs was not statistically significant. It is possible that the current use of LMWH for VTE prophylaxis may have reduced the impact that prophylactic IVC filters have on the incidence of PEs. The investigations cited above that showed significant reductions of PEs after PIVCF use are older studies. The benefits of LMWH may not have been fully realized at that time. More recently, Antevil et al. 8 also reported a threefold increase in prophylactic retrievable IVF filters. Their low PE rate of 0.2% remained unchanged. Interestingly, McMurty et al. 9 actually found a significantly higher incidence of PE following a period of high PIVCF use. The cost-effectiveness of IVC filters in the prevention of PE among trauma patients has been questioned previously. 10,11 In our study, the sample size is probably not large enough to analyze a statistically significant reduction in the PE rate. The PE rate would need to decrease to 0.1% to obtain a p value of 0.45 at 80% power. On the other hand, to have a PE rate 0.1%, there would need to be no more than one PE among the 1,811 patients in Because one of the PEs occurred on postprocedure day 14 after implantation of a PIVCF in 2006, this would mean that none of the 1,684 without an IVC filter would be allowed to have a PE. This outcome measurement is probably not possible to achieve clinically. The overall incidence of PEs in our state is 0.6% with a mortality rate of 8.5% in In order for prophylactic IVC filters to result in meaningful reductions in the incidence in PE, there is a need for better defined risk factors for VTE and improved indications for prophylaxis. Age, spine fractures, prolonged ventilator days, major venous injury, major operative procedure, lower 546 September 2008

4 Prophylactic IVC Filters extremity fractures and closed head injury with AIS 3 should also be considered. 2,13 The difficulty, however, is to develop strategies of risk stratification that minimize the number of unnecessary prophylactic IVC filters. 14 In an era in which the Centers for Medicare and Medicaid Services is discontinuing coverage for selected hospital complications, additional studies are needed to reduce or eliminate the incidence of pulmonary embolism. The four patients who suffered a PE despite an IVC filter were particularly concerning. Although the time to filter implant had a wide range in our study (0 32 days), there is no indication that this had a possible effect on these four patients. They were noted to be implanted on hospital days 2, 4, 8, and 13. Three of these patients were diagnosed after developing acute respiratory distress. Bilateral PEs were found in one patient following a surveillance CT scan for a grade IV liver laceration. This patient was asymptomatic at the time and had their IVC filter placed on hospital day 13. There are several possible reasons for the occurrence of a PE despite IVC filter placement. First, clot may have embolized and extruded through the filter. Second, an upper extremity DVT may have embolized to the pulmonary veins. The incidence of pulmonary embolism among inpatients with a known upper extremity DVT has been reported to be 0% to 28%. 15 The presence of a duplicated vena cava system or circumaortic renal vein may also allow for emboli to bypass the filter. However, these anomalies were excluded with a prefilter placement cavagram and review of the preprocedure CT scan. Of note, in all four of these patients with a post- IVCF PE, LMWH was either held or not started at all because of the risk for bleeding. All of this suggests that prophylaxis with low dose heparin or LMWH is still important in patients with a PIVCF as soon as any contraindications have been resolved. There have been several reports of PEs occurring in trauma patients after IVC filter insertion. 8,14,16 18 Rogers et al. 18 investigated 132 prophylactic Greenfield filters implanted. This study reported a 3.1% insertion-related DVT rate, a 5.5% incidence of filter tilt, and a 38% prevalence of strut malposition. They reported three cases of PE occurring after IVC filter placement. All of these PEs were associated with either strut malposition or filter tilt. Rogers concluded that strut malposition and filter tilt greater than or equal to 14 for the Greenfield filter was a risk factor for PE. Of note, all of these cases involved the Greenfield filter. In our study, three of the four of the patients who developed postprocedure PEs had retrievable filters placed. All three had their IVC filters removed. There was no reported filter tilt or strut malposition in any of these patients during the retrieval. Patton et al. 19 reported an early IVC complication rate of 7% among 110 patients with prophylactic IVCF. Malpositioning was reported in three patients and significant migration in one patient. There were no reported postfilter PEs. The most common complication in trauma patients with following prophylactic IVC filters is a DVT. Girard et al. 20 performed a systematic review of the literature and found the DVT rate to be 9.3% among 1,112 patients. The DVT rate of 9.0% found in this study is consistent with their study. The DVT rate among those patients with a PIVCF decreased from 24.1% in 2004 to 8.0% in 2005 and 6.3% in There has been no significant change in our duplex screening practice. The use of DVT prophylaxis with LMWH (dalteparin), after contraindications no longer existed, remained the agent of choice throughout this period. We are therefore unable to explain the decrease in the DVT rate over the 3-year period among patients who underwent IVC filter placement. To our knowledge, the IVC filter removal rate of 59% is the highest reported in the literature to date. The removal rate has ranged from 21% to 52%. 8,16,21,22 In a recent multicenter study by Karmy-Jones et al. 21 involving 21 trauma centers, the IVC removal rate was reported to be 21%. The authors found a sixfold increase in IVC filters when the service that placed the retrievable filter was also responsible for outpatient care with respect to the filter. The high removal rate of 59% in our study was achieved through the joint collaboration between trauma and interventional radiology. There has been some discussion in the literature about the optimal timing for IVC filter retrieval. Stefanidis et al. 23 suggested that trauma patients should have recovered from their injuries and be at least 30 days postdischarge, or be on a stable regimen of therapeutic anticoagulation for the treatment of a DVT or PE for at least 2 weeks. During outpatient follow-up visits at our institution, the original indications for IVC filters were again reviewed with the patient, as well as the process for retrieval of the filter. Removal was recommended if the patient was on a stable regimen of anticoagulation therapy or ambulating greater than 150 feet per day without the use of assist devices, such as a canes or walker. At the same time, Interventional Radiology maintained a database of all retrievable IVC filters implanted and contacted patients periodically about potential removal during their outpatient course. Of note, there were 4,656 patients who did not receive an IVC filter over the 3-year period. We think that future studies should include all trauma patients who may be eligible for an IVC filter, evaluate their clinical outcomes, including the incidence of VTE, and compare eligible patients who did receive an IVC filter with those who did not have one implanted. In conclusion, there was a statistically significant increase in PIVCF increase over 3 years without an impact on the overall PE rate among trauma patients. There was a 1.6% incidence of PE despite IVCF prophylaxis and a 9.0% DVT rate. The PIVCF group, however, had a relatively high retrieval rate (59%), a low rate of filter-related technical complications (0.1%), and satisfactory compliance with traditional EAST guidelines. PIVCF were removed safely greater than 800 days postprocedure. The instructions for use (IFU) for the Gunther Tulip Filter (Cook Group, Bloomington, IN) and the Recovery/G2 filters (Bard Peripheral Vas- Volume 65 Number 3 547

5 cular, Tempe, AZ) state no specific recommendations or limitations regarding the timing of filter retrieval. The results of this study contribute to the body of literature placing the effectiveness of IVC filters in doubt. The current criteria used for determining which patients will benefit are not sufficient enough to have an effect at reducing the overall rate of PE. Further investigation is required to define an optimal trauma population that lends itself prophylactic IVC filter placement. REFERENCES 1. Velmahos GC, Kern J, Chan LS, Oder D, Murray JA, Shekelle P. Prevention of venous thromboembolism after injury: an evidencebased report. Part II: Analysis of risk factors and evaluation of the role of vena caval filters. J Trauma. 2000;49: Velmahos GC, Kern J, Chan LS, Oder D, Murray JA, Shekelle P. Prevention of venous thromboembolism after injury: an evidencebased report. Part I: Analysis of risk factors and evaluation of the role of vena caval filters. J Trauma. 2000;49: Rogers FB, Cipolle MD, Velmahos G, Rozycki G, Luchette FA. Practice management Guidelines for the Prevention of Venous Thromboembolism in Trauma Patients: The EAST Practice Management Guidelines Work Group. J Trauma. 2002;53: Giannoudis PV, Pountos I, Pape CH, Patel JV. Safety and efficacy of vena cava filters in trauma patients. Injury. 2007;38: Rogers FB, Shackford SR, Wilson J, Ricci MA, Morris CS. Prophylactic vena cava filter insertion in severely injured trauma patients: indications and preliminary results. J Trauma. 1993;35: Rogers FB, Shackford SR, Ricci MA, Wilson JT, Parsons S. Routine prophylactic vena cava filter insertion in severely injured trauma patients decreases the incidence of pulmonary embolism. J Am Coll Surg. 1995;180: Gosin JS, Graham AM, Ciocca RG, Hammond JS. Efficacy of prophylactic vena cava filters in high-risk trauma patients. Ann Vasc Surg. 1997;11: Antevil JL, Sise MJ, Sack DI, et al. Retrevable vena cava filters for preventing pulmonary embolism in trauma patients: a cautionary tale. J Trauma. 2006;60: McMurty AL, Owings JT, Anderson JT, Battistella FD, Gosselin R. Increased use of prophylactic vena cava filters in trauma patients failed to decrease overall incidence of pulmonary embolism. JAm Coll Surg. 1999;189: Brasel KJ, Borgstrom DC, Weigelt JA. Cost-effective prevention of pulmonary embolus in high-risk trauma patients. J Trauma. 1997; 42: Spain DA, Richardson JD, Polk HC Jr, Bergamini TM, Wilson MA, Miller FB. Venous thromboembolism in the high-risk trauma patient: do risks justify aggressive screening and prophylaxis. J Trauma. 1997;42: Pennsylvania Trauma Outcome Study: 2006 Occurrence Report, Pennsylvania Trauma Systems Foundation, Mechanicsburg, PA. 13. Knudson MM, Ikossi DG, Khaw L, Morabito D. Thromboembolism after trauma: an analysis of 1602 episodes from the American college of Surgeons National Trauma Data Bank. Ann Surg. 2004; 240: Greenfield LJ, Proctor MC, Michales AJ, Taheri PA. Prophylactic vena caval filters in trauma: the rest of the story. J Vasc Surg. 2000; 32: Hingorani A, Ascher E, Lorenson E, et al. Upper extremity deep venous thrombosis and its impact on morbidity and mortality in a hospital-based population. J Vasc Surg. 1997;26: Rosenthal D, Wellons ED, Lai KM, Bikk A, Henderson VJ. Retrievable inferior vena cava filters: initial clinical results. Ann Vasc Surg. 2006;20: Langan EM III, Miller RS, Casey WJ III, Carsten CG III, Graham RM, Taylor SM. Prophylactic inferior vena cava filters in trauma patients at high risk: follow-up examination and risk/benefit assessment. J Vasc Surg. 1999;30: Rogers FB, Strindberg G, Shackford SR, et al. Five-year follow-up of prophylactic vena cava filters in high-risk trauma patients. Arch Surg. 1998;133: Patton JH Jr, Fabian TC, Croce MA, Minard G, Pritchard FE, Kudsk KA. Prophylactic Greenfield filters: acute complications and long term follow-up. J Trauma. 1996;41: Girard TD, Philbrick JT, Angle JF, Becker DM. Prophylactic vena cava filters for trauma patients: a systematic review of the literature. Thrombosis Res. 2003;112: Karmy-Jones R, Jurkovich GL, Velmahos GC. Practice patterns and outcomes of retrievable vena cava filters in trauma patients: An AAST Multicenter Study. J Trauma. 2007;62: Kirilcuk NN, Herget EJ, Dicker RA, Spain DA, Hellinger JC, Brundage SI. Are temporary inferior vena cava filters really temporary. Am J Surg. 2005;190: Stefanidis D, Paton BL, Jacobs DG, et al. Extended interval for retrieval of vena cava filters is safe and may maximize protection against pulmonary embolism. Am J Surg. 2006;192: September 2008

Inferior Vena Cava Filters- Are they Followed up? By Dr Nathalie van Havre Dr Chamica Wijesinghe Dr Kieren Brown

Inferior Vena Cava Filters- Are they Followed up? By Dr Nathalie van Havre Dr Chamica Wijesinghe Dr Kieren Brown Inferior Vena Cava Filters- Are they Followed up? By Dr Nathalie van Havre Dr Chamica Wijesinghe Dr Kieren Brown Introduction Trousseau (1868) first described interruption to inferior vena cava (IVC) to

More information

THROMBOEMBOLIC EVENTS AFTER IVC FILTER PLACEMENT IN TRAUMA PATIENTS. Lidie Lajoie, MD SUNY Downstate Department of Surgery December 20, 2012

THROMBOEMBOLIC EVENTS AFTER IVC FILTER PLACEMENT IN TRAUMA PATIENTS. Lidie Lajoie, MD SUNY Downstate Department of Surgery December 20, 2012 THROMBOEMBOLIC EVENTS AFTER IVC FILTER PLACEMENT IN TRAUMA PATIENTS Lidie Lajoie, MD SUNY Downstate Department of Surgery December 20, 2012 Background Trauma Patients at High Risk for VTE Spain, D.A.,

More information

Inferior Venacaval Filters Valuable vs. Dangerous Valuable Annie Kulungowski. Department of Surgery Grand Rounds March 24, 2008

Inferior Venacaval Filters Valuable vs. Dangerous Valuable Annie Kulungowski. Department of Surgery Grand Rounds March 24, 2008 Inferior Venacaval Filters Valuable vs. Dangerous Valuable Annie Kulungowski Department of Surgery Grand Rounds March 24, 2008 History of Vena Cava Filters Virchow-1846-Proposes PE originate from veins

More information

Post-Traumatic Thromboembolism. Pathogenesis, Diagnosis and Prevention M. Margaret Knudson, MD

Post-Traumatic Thromboembolism. Pathogenesis, Diagnosis and Prevention M. Margaret Knudson, MD Post-Traumatic Thromboembolism Pathogenesis, Diagnosis and Prevention M. Margaret Knudson, MD Historical Perspectives A study of protocols of 9,882 postmortem exams including death from injury in the traumatic

More information

IVC Filters: For Whom, Why and When?

IVC Filters: For Whom, Why and When? IVC Filters: For Whom, Why and When? Dariusz Zawierucha, MD Interventional & Diagnostic Radiology Radiology Associates, PC 1 Disclosures: I have no financial conflicts to disclose. I do not endorse any

More information

VTE in the Trauma Population

VTE in the Trauma Population VTE in the Trauma Population Erik Peltz, D.O. February 11 th, 2015 * contributions from Eduardo Gonzalez, M.D. University of Colorado T-32 Research Fellow The problem. VTE - Scope of the Problem One of

More information

Copyright Protected. There is considerable debate over what constitutes. Inferior Vena Cava Filter Placement in Orthopedic Surgery

Copyright Protected. There is considerable debate over what constitutes. Inferior Vena Cava Filter Placement in Orthopedic Surgery An Original Study Inferior Vena Cava Filter Placement in Orthopedic Surgery Anne R. Bass, MD, Christopher J. Mattern, MD, MBA, James E. Voos, MD, Margaret G. E. Peterson, PhD, and David W. Trost, MD Abstract

More information

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM International Consensus Statement 2013 Guidelines According to Scientific Evidence Developed under the auspices of the: Cardiovascular Disease Educational

More information

INFERIOR VENA CAVA FILTERS QUIZ 10 QUESTIONS MAY 5, 2014

INFERIOR VENA CAVA FILTERS QUIZ 10 QUESTIONS MAY 5, 2014 INFERIOR VENA CAVA FILTERS QUIZ 10 QUESTIONS MAY 5, 2014 QUESTION 1 1. Anatomically Transposition of the IVC is observed in what % of individuals A) 1-5% B).2-.05% C) 3-5% D) 5-10% ANSWER QUESTION 1 Answer

More information

Prevention of Venous Thromboembolism in High-Risk Patients

Prevention of Venous Thromboembolism in High-Risk Patients Prevention of Venous Thromboembolism in High-Risk Patients William H. Geerts The prevention of venous thromboembolism (VTE) in patients recovering from major trauma, spinal cord injury (SCI), or other

More information

Prophylactic inferior vena cava filters in trauma patients at high risk: Follow-up examination and risk/benefit assessment

Prophylactic inferior vena cava filters in trauma patients at high risk: Follow-up examination and risk/benefit assessment Prophylactic inferior vena cava filters in trauma patients at high risk: Follow-up examination and risk/benefit assessment Eugene M. Langan III, MD, Richard S. Miller, MD, William J. Casey III, MD, Christopher

More information

Trauma Measure #3 Venous Thromboembolism (VTE) Prophylaxis in Abdominal Trauma. National Quality Strategy (NQS) Domain: Patient Safety

Trauma Measure #3 Venous Thromboembolism (VTE) Prophylaxis in Abdominal Trauma. National Quality Strategy (NQS) Domain: Patient Safety Trauma Measure #3 Venous Thromboembolism (VTE) Prophylaxis in Abdominal Trauma National Quality Strategy (NQS) Domain: Patient Safety Measure Type (Process/Outcome): Process 2016 PQRS OPTIONS FOR INDIVIDUAL

More information

Deep Venous Thrombosis, Pulmonary Embolus and IVC Filters. Michael Meuse, M.D. Vascular and Interventional Radiology

Deep Venous Thrombosis, Pulmonary Embolus and IVC Filters. Michael Meuse, M.D. Vascular and Interventional Radiology Deep Venous Thrombosis, Pulmonary Embolus and IVC Filters Michael Meuse, M.D. Vascular and Interventional Radiology Pulmonary Embolism and DVT Estimated 570,000 to 650,000 cases of symptomatic PE each

More information

The association between injury and venous thromboembolic

The association between injury and venous thromboembolic ORIGINAL ARTICLE An Analysis of 1602 Episodes From the American College of Surgeons National Trauma Data Bank M. Margaret Knudson, MD, FACS, Danagra G. Ikossi, MD, Linda Khaw, BA, Diane Morabito, RN, MPH,

More information

Cost-effective prevention of pulmonary embolus in high-risk trauma patients Brasel K J, Borgstrom D C, Weigelt J A

Cost-effective prevention of pulmonary embolus in high-risk trauma patients Brasel K J, Borgstrom D C, Weigelt J A Cost-effective prevention of pulmonary embolus in high-risk trauma patients Brasel K J, Borgstrom D C, Weigelt J A Record Status This is a critical abstract of an economic evaluation that meets the criteria

More information

Clinical Implications of the Impact of Serum Tissue Factor Levels after Trauma

Clinical Implications of the Impact of Serum Tissue Factor Levels after Trauma Clinical Implications of the Impact of Serum Tissue Factor Levels after Trauma Ian E. Brown, MD, PhD, and Joseph M. Galante MD, FACS Formatted: Font: 16 pt, Bold Formatted: Centered Formatted: Font: Bold

More information

Clinical Guide - Inferior Vena Cava Filters (Reviewed 2006)

Clinical Guide - Inferior Vena Cava Filters (Reviewed 2006) Clinical Guide - Inferior Vena Cava Filters (Reviewed 2006) Principal Developer: V. Oliva Secondary Developers: W. Geerts Background The treatment of choice for deep venous thrombosis (DVT) and pulmonary

More information

Special comment. (inferior vena cava filter, IVCF) Mobin-Uddin % [4] 1 IVCF

Special comment. (inferior vena cava filter, IVCF) Mobin-Uddin % [4] 1 IVCF 340 Special comment ; ; ; :R543.6 :A :1008-794X(2011)-05-0340-05 The consensus among Chinese interventional experts on the standard of inferior vena cava filter insertion and retrieval Academic Group of

More information

Inferior Vena Cava Filters

Inferior Vena Cava Filters Inferior Vena Cava Filters and the American Society of Hematology Choosing Wisely Campaign Kevin P. Hubbard, DO, HMDC MACOI Chief - Division of Specialty Medicine Professor and Chair - Section of Internal

More information

Joint Theater Trauma System Clinical Practice Guideline

Joint Theater Trauma System Clinical Practice Guideline THE PREVENTION OF DEEP VENOUS THROMBOSIS IVC Filter Original Release/Approval 25 Dec 2004 Note: This CPG requires an annual review. Reviewed: Mar 2012 Approved: 24 Apr 2012 Supersedes: The Prevention of

More information

Venous thrombotic, thromboembolic, and mechanical complications after retrievable inferior vena cava filters for major trauma

Venous thrombotic, thromboembolic, and mechanical complications after retrievable inferior vena cava filters for major trauma British Journal of Anaesthesia 114 (1): 63 9 (2015) Advance Access publication 30 June 2014. doi:10.1093/bja/aeu195 CLINICAL PRACTICE Venous thrombotic, thromboembolic, and mechanical complications after

More information

IVC filter retrieval program effects on retrieval rates and number of patients lost to follow-up

IVC filter retrieval program effects on retrieval rates and number of patients lost to follow-up IVC filter retrieval program effects on retrieval rates and number of patients lost to follow-up Aliaksei Salei, MD; Joel Raborn, MD; Padma P. Manapragada, MD; Ahmed Kamel Abdel Aal, MD/PhD; AJ Gunn, MD

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Mismetti P, Laporte S, Pellerin O, Ennezat P-V, Couturaud F, Elias A, et al. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone

More information

Inferior Vena Cava Filter Retrieval

Inferior Vena Cava Filter Retrieval Inferior Vena Cava Filter Retrieval Tips on the best methods for retrieving an IVC filter. BY THUONG G. VAN HA, MD Studies have shown that inferior vena cava (IVC) filters are effective in the prevention

More information

Bard Meridian Filter Fracture

Bard Meridian Filter Fracture Bard Meridian Filter Fracture The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation As Published Publisher Wu, Alex et al. Bard

More information

IVC Filters: Rate of Insertion, Indications, Effects on Prognosis, Evidence Basis for Current Practices. Paul D. Stein, MD

IVC Filters: Rate of Insertion, Indications, Effects on Prognosis, Evidence Basis for Current Practices. Paul D. Stein, MD IVC Filters: Rate of Insertion, Indications, Effects on Prognosis, Evidence Basis for Current Practices Paul D. Stein, MD Professor Department of Osteopathic Medical Specialties College of Osteopathic

More information

I am NOT: Disclosures. The Problem of the Con-Position Non Thinking! Against New Ideas. Against New Therapies. Against Endovascular Therapies

I am NOT: Disclosures. The Problem of the Con-Position Non Thinking! Against New Ideas. Against New Therapies. Against Endovascular Therapies Inferior Vena Cava Filters: Disclosures A Love /Hate (Mostly Hate) Relationship Lack of Political Correctness Gregory L. Moneta, M.D. Professor and Chief, Vascular Surgery Oregon Health & Science University

More information

CPT only copyright 2014 American Medical Association. All rights reserved. 12/23/2014 Page 66 of 593

CPT only copyright 2014 American Medical Association. All rights reserved. 12/23/2014 Page 66 of 593 Measure #23 (NQF 0239): Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) National Quality Strategy Domain: Patient Safety 2015 PQRS OPTIONS FOR INDIVIDUAL MEASURES:

More information

Venous thromboembolism (VT) is a significant cause of

Venous thromboembolism (VT) is a significant cause of Prevention of Venous Thromboembolism after Injury: An Evidence-Based Report Part II: Analysis of Risk Factors and Evaluation of the Role of Vena Caval Filters George C. Velmahos, MD, PhD, Jack Kern, PharmD,

More information

Thromboembolic events (TEs), such as deep vein

Thromboembolic events (TEs), such as deep vein An Original Study Use of Low-Molecular-Weight Heparin and a Deep Vein Thrombosis Protocol to Prevent DVT in Elderly Patients With Trauma Douglas J.E. Schuerer, MD, and Joseph Borrelli, Jr., MD Abstract

More information

EAST MULTICENTER STUDY DATA DICTIONARY

EAST MULTICENTER STUDY DATA DICTIONARY EAST MULTICENTER STUDY DATA DICTIONARY Does the Addition of Daily Aspirin to Standard Deep Venous Thrombosis Prophylaxis Reduce the Rate of Venous Thromboembolic Events? Data Entry Points and appropriate

More information

From the Society for Vascular Surgery

From the Society for Vascular Surgery From the Society for Vascular Surgery Role of prophylactic temporary inferior vena cava filters placed at the ICU bedside under intravascular ultrasound guidance in patients with multiple trauma David

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #23 (NQF 0239): Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) National Quality Strategy Domain: Patient Safety 2018 OPTIONS FOR INDIVIDUAL MEASURES:

More information

DENOMINATOR: All surgical patients aged 18 years and older undergoing procedures for which VTE prophylaxis is indicated in all patients

DENOMINATOR: All surgical patients aged 18 years and older undergoing procedures for which VTE prophylaxis is indicated in all patients Measure #23 (NQF 0239): Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) National Quality Strategy Domain: Patient Safety 2017 OPTIONS FOR INDIVIDUAL MEASURES:

More information

Early Pharmacologic Venous Thromboembolism (VTE) prophylaxis is NOT indicated in Traumatic Brain Injury

Early Pharmacologic Venous Thromboembolism (VTE) prophylaxis is NOT indicated in Traumatic Brain Injury Early Pharmacologic Venous Thromboembolism (VTE) prophylaxis is NOT indicated in Traumatic Brain Injury Nefertiti A. Brown, MD Morbidity & Mortality Conference SUNY Downstate Medical Center Department

More information

A national survey of thromboprophylaxis strategies in high risk trauma patients.

A national survey of thromboprophylaxis strategies in high risk trauma patients. Research Article http://www.alliedacademies.org/trauma-and-critical-care/ A national survey of thromboprophylaxis strategies in high risk trauma patients. R Mason Curtis 1*, Kelly Vogt 2, W Robert Leeper

More information

Venous Thromboembolism. Prevention

Venous Thromboembolism. Prevention Venous Thromboembolism Prevention August 2010 Venous Thromboembloism Prevention 1 1 Expected Practice Assess all patients upon admission to the ICU for risk factors of venous thromboembolism (VTE) and

More information

IVC FILTERS: A CASE REPORT REVIEWING THE INDICATIONS FOR PLACEMENT, RETRIEVAL AND ANTICOAGULATION

IVC FILTERS: A CASE REPORT REVIEWING THE INDICATIONS FOR PLACEMENT, RETRIEVAL AND ANTICOAGULATION IVC FILTERS: A CASE REPORT REVIEWING THE INDICATIONS FOR PLACEMENT, RETRIEVAL AND ANTICOAGULATION Resident(s): George Athanasatos Attending(s): Daniel Golwyn Program/Dept: Interventional Radiology CHIEF

More information

Venous Thromboembolism Prophylaxis

Venous Thromboembolism Prophylaxis Approved by: Venous Thromboembolism Prophylaxis Vice President and Chief Medical Officer; and Vice President and Chief Operating Officer Corporate Policy & Procedures Manual Number: Date Approved January

More information

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM International Consensus Statement 2013 Guidelines According to Scientific Evidence Developed under the auspices of the: Cardiovascular Disease Educational

More information

J Jpn Coll Angiol, 2009, 49:

J Jpn Coll Angiol, 2009, 49: Online publication August 27, 2009 1 2 J Jpn Coll Angiol, 2009, 49: 247 254 deep vein thrombosis, thrombolytic therapy, catheter-directed thrombolysis, inferior vena cava filter, pulmonary thromboembolism

More information

Spontaneous Tilting after Placement of the Gu nther-tulip Inferior Vena Caval Filter: A Case Report 1

Spontaneous Tilting after Placement of the Gu nther-tulip Inferior Vena Caval Filter: A Case Report 1 Spontaneous Tilting after Placement of the Gu nther-tulip Inferior Vena Caval Filter: Case Report 1 Tae-Seok Seo, M.D., In-Ho Cha, M.D., Hae Young Seol, M.D., Cheol Min Park, M.D. Tilting of a deployed

More information

IVC Filters: A new era of responsibility

IVC Filters: A new era of responsibility IVC Filters: A new era of responsibility Stephen L. Wang, MD Lead Physician, KP National IVC Filter Registry Director, IVC Filter Clinic KP Santa Clara Vascular/Interventional Radiology Disclosure of Relevant

More information

Top Ten Reasons For Failure To Prevent Postoperative Thrombosis

Top Ten Reasons For Failure To Prevent Postoperative Thrombosis Top Ten Reasons For Failure To Prevent Postoperative Thrombosis Joseph A. Caprini, MD, MS, FACS, RVT, FACCWS Louis W. Biegler Chair of Surgery NorthShore University HealthSystem, Evanston, IL Clinical

More information

Screening and Management of Blunt Cereberovascular Injuries (BCVI)

Screening and Management of Blunt Cereberovascular Injuries (BCVI) Grady Memorial Hospital Trauma Service Guidelines Screening and Management of Blunt Cereberovascular Injuries (BCVI) BACKGROUND Blunt injury to the carotid or vertebral vessels (blunt cerebrovascular injury

More information

Cost-effectiveness of guidelines for insertion of inferior vena cava filters in high-risk trauma patients

Cost-effectiveness of guidelines for insertion of inferior vena cava filters in high-risk trauma patients From the American Venous Forum Cost-effectiveness of guidelines for insertion of inferior vena cava filters in high-risk trauma patients Emily L. Spangler, MD, a Ellen D. Dillavou, MD, b and Kenneth J.

More information

Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (2012) NICE guideline CG144

Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (2012) NICE guideline CG144 Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (2012) NICE guideline CG144 Appendix A: Summary of new evidence from Summary of evidence from previous year Diagnosis Diagnostic

More information

Thrombosis & Hemostasis Summit of North America 2016Apr16. IVC Filters

Thrombosis & Hemostasis Summit of North America 2016Apr16. IVC Filters Thrombosis & Hemostasis Summit of North America 2016Apr16 IVC Filters Bill Geerts, MD, FRCPC Thromboembolism Consultant, Sunnybrook HSC Professor of Medicine, University of Toronto National Lead, VTE Prevention,

More information

DVT - initial management NSCCG

DVT - initial management NSCCG Background information Information resources for patients and carers Updates to this care map Synonyms Below knee DVT and bleeding risks Patient with confirmed DVT Scan confirms superficial thrombophlebitis

More information

VENOUS THROMBOEMBOLISM (VTE) PREVENTION MEDICAL PROVIDER EDUCATION JUNE 2017

VENOUS THROMBOEMBOLISM (VTE) PREVENTION MEDICAL PROVIDER EDUCATION JUNE 2017 VENOUS THROMBOEMBOLISM (VTE) PREVENTION MEDICAL PROVIDER EDUCATION JUNE 2017 VTE IS THE 2 ND MOST COMMON HOSPITAL ACQUIRED CONDITION RISK FACTORS DECREASED ACTIVITY = VTE RISK (NURSES MEASURE WITH BRADEN

More information

Perforated inferior vena cava filter removal by concurrent femoral and internal jugular vein approaches

Perforated inferior vena cava filter removal by concurrent femoral and internal jugular vein approaches www.edoriumjournals.com CLINICAL IMAGES PEER REVIEWED OPEN ACCESS Perforated inferior vena cava filter removal by concurrent femoral and internal jugular vein approaches Raymond Yap, Ankur Sidhu, Mark

More information

Misunderstandings of Venous thromboembolism prophylaxis

Misunderstandings of Venous thromboembolism prophylaxis Misunderstandings of Venous thromboembolism prophylaxis Veerendra Chadachan Senior Consultant Dept of General Medicine (Vascular Medicine and Hypertension) Tan Tock Seng Hospital, Singapore Case scenario

More information

Clinical Practice Management Guideline for Venous Thromboembolism Prevention

Clinical Practice Management Guideline for Venous Thromboembolism Prevention Clinical for Venous Thromboembolism Prevention Goals 1. Identify patients at risk for developing venous thromboembolism after a traumatic mechanism. 2. Utilize the medication and dosing appropriate for

More information

Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales

Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales Merimbula, 6 th November 2010 University of Sydney Department of Surgery Westmead Hospital

More information

Disclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None

Disclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None Disclosures DVT: Diagnosis and Treatment None Susanna Shin, MD, FACS Assistant Professor University of Washington Acute Venous Thromboembolism (VTE) Deep Venous Thrombosis (DVT) Pulmonary Embolism (PE)

More information

VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT

VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT OBJECTIVE: To provide guidance on the recommended duration of anticoagulant therapy for venous thromboembolism (VTE). BACKGROUND: Recurrent episodes of VTE

More information

AN AUDIT: THROMBOPROPHYLAXIS FOR TOTAL HIP REPLACEMENT PATIENTS AT NORTHWICK PARK AND CENTRAL MIDDLESEX HOSPITALS

AN AUDIT: THROMBOPROPHYLAXIS FOR TOTAL HIP REPLACEMENT PATIENTS AT NORTHWICK PARK AND CENTRAL MIDDLESEX HOSPITALS The West London Medical Journal 2010 Vol 2 No 4 pp 19-24 AN AUDIT: THROMBOPROPHYLAXIS FOR TOTAL HIP REPLACEMENT PATIENTS AT NORTHWICK PARK AND CENTRAL MIDDLESEX HOSPITALS Soneji ND Agni NR Acharya MN Anjari

More information

NICE Guidance: Venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital 1

NICE Guidance: Venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital 1 The College of Emergency Medicine Patron: HRH The Princess Royal Churchill House Tel +44 (0)207 404 1999 35 Red Lion Square Fax +44 (0)207 067 1267 London WC1R 4SG www.collemergencymed.ac.uk CLINICAL EFFECTIVENESS

More information

ORIGINAL INVESTIGATION. Indications, Complications, and Management of Inferior Vena Cava Filters

ORIGINAL INVESTIGATION. Indications, Complications, and Management of Inferior Vena Cava Filters LESS IS MORE ORIGINAL INVESTIGATION Indications, Complications, and Management of Inferior Vena Cava Filters The Experience in 952 Patients at an Academic Hospital With a Level I Trauma Center Shayna Sarosiek,

More information

M Johnson Disclosures

M Johnson Disclosures 2/22/2013 IVC Filters: Current Controversies and the PRESERVE Study Matthew S Johnson MD FSIR Indiana University School of Medicine M Johnson Disclosures Speaking and Teaching Bayer Cook Nordion Research

More information

Saman Arbabi M.D., M.P.H., F.A.C.S. Kathleen O'Connell M.D. Bryce Robinson M.D., M.S., F.A.C.S., F.C.C.M

Saman Arbabi M.D., M.P.H., F.A.C.S. Kathleen O'Connell M.D. Bryce Robinson M.D., M.S., F.A.C.S., F.C.C.M Form "EAST Multicenter Study Proposal" Study Title Primary investigator / Senior researcher Email of Primary investigator / Senior researcher Co-primary investigator Are you a current member of EAST? If

More information

LIMB COMPRESSION DEVICES FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS

LIMB COMPRESSION DEVICES FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS PROPHYLAXIS Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are dependent

More information

Patterns of Failure of a Standardized Perioperative Venous Thromboembolism Prophylaxis Protocol

Patterns of Failure of a Standardized Perioperative Venous Thromboembolism Prophylaxis Protocol Patterns of Failure of a Standardized Perioperative Venous Thromboembolism Prophylaxis Protocol Ryan Macht MD, Michael Cassidy MD, Pamela Rosenkranz RN BSN MEd, Joseph Caprini MD FACS, David McAneny MD

More information

Interventional Treatment VTE: Radiologic Approach

Interventional Treatment VTE: Radiologic Approach Interventional Treatment VTE: Radiologic Approach Hae Giu Lee, MD Professor, Dept of Radiology Seoul St. Mary s Hospital The Catholic University of Korea Introduction Incidence High incidence: 250,000-1,000,000/year

More information

Handbook for Venous Thromboembolism

Handbook for Venous Thromboembolism Handbook for Venous Thromboembolism Gregory Piazza Benjamin Hohlfelder Samuel Z. Goldhaber Handbook for Venous Thromboembolism Gregory Piazza Cardiovascular Division Harvard Medical School Brigham and

More information

Mabel Labrada, MD Miami VA Medical Center

Mabel Labrada, MD Miami VA Medical Center Mabel Labrada, MD Miami VA Medical Center *1-Treatment for acute DVT with underlying malignancy is for 3 months. *2-Treatment of provoked acute proximal DVT can be stopped after 3months of treatment and

More information

VIVO-EU Results: Prospective European Study of the Zilver Vena TM Venous Stent in the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction

VIVO-EU Results: Prospective European Study of the Zilver Vena TM Venous Stent in the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction VIVO-EU Results: Prospective European Study of the Zilver Vena TM Venous Stent in the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction Gerard J O Sullivan, M.D. and Jennifer McCann-Brown,

More information

Interventional Radiology in Trauma. Vikash Prasad, MD, FRCPC Vascular and Interventional Radiology The Moncton Hospital

Interventional Radiology in Trauma. Vikash Prasad, MD, FRCPC Vascular and Interventional Radiology The Moncton Hospital Interventional Radiology in Trauma Vikash Prasad, MD, FRCPC Vascular and Interventional Radiology The Moncton Hospital Disclosures None relevant to this presentation Shareholder Johnson and Johnson Goal

More information

Risk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD

Risk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD Risk factors for DVT Venous thrombosis & pulmonary embolism Ahmed Mahmoud, MD Surgery ; post op especially for long cases, pelvic operations (THR), Trauma ; long bone fractures, pelvic fractures (posterior

More information

Venous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD

Venous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD Venous thrombosis & pulmonary embolism Ahmed Mahmoud, MD Risk factors for DVT Surgery ; post op especially for long cases, pelvic operations (THR), Trauma ; long bone fractures, pelvic fractures (posterior

More information

THROMBOPROPHYLAXIS: NON-ORTHOPEDIC SURGERY

THROMBOPROPHYLAXIS: NON-ORTHOPEDIC SURGERY THROMBOPROPHYLAXIS: NON-ORTHOPEDIC SURGERY OBJECTIVE: To outline a practical approach for the prevention of venous thromboembolism (VTE) in patients undergoing non-orthopedic surgery. BACKGROUND: VTE is

More information

Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism

Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism Summary Number 68 Overview Venous thromboembolism

More information

Adam Goldfarb, M.A., D.C., D.E.S.S. Introduction

Adam Goldfarb, M.A., D.C., D.E.S.S. Introduction Venous Thromboembolism Prophylaxis following Lower Extremity Orthopedic Surgery: A Review of the Biomedical Research Literature and Evidence-Based Policy in the United States. Adam Goldfarb, M.A., D.C.,

More information

Pharmacy Prior Authorization

Pharmacy Prior Authorization Pharmacy Prior Authorization AETA BETTER HEALTH EW JERSE (MEDICAID) Anticoagulant Injectable (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review

More information

What You Should Know

What You Should Know 1 New 2018 ASH Clinical Practice Guidelines on Venous Thromboembolism: What You Should Know New 2018 ASH Clinical Practice Guidelines on Venous Thromboembolism: What You Should Know The American Society

More information

INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY

INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY N.E. Pearce INTRODUCTION Preventable death Cause of morbidity and mortality Risk factors Pulmonary embolism

More information

Anticoagulation for prevention of venous thromboembolism

Anticoagulation for prevention of venous thromboembolism Anticoagulation for prevention of venous thromboembolism Original article by: Michael Tam Note: updated in June 2009 with the eighth edition (from the seventh) evidence-based clinical practice guidelines

More information

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM Gordon Lowe Professor of Vascular Medicine University of Glasgow VENOUS THROMBOEMBOLISM Common cause of death and disability 50% hospital-acquired

More information

Division of Vascular Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 2

Division of Vascular Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 2 Vascular Specialist International Vol. 34, No. 4, December 2018 pissn 2288-7970 eissn 2288-7989 Clinical Outcomes of a Preoperative Inferior Vena Cava Filter in Acute Venous Thromboembolism Patients Undergoing

More information

The Eastern Association for the Surgery of Trauma

The Eastern Association for the Surgery of Trauma CLINICAL MANAGEMENT UPDATE The Journal of TRAUMA Injury, Infection, and Critical Care Practice Management Guidelines for the Prevention of Venous Thromboembolism in Trauma Patients: The EAST Practice Management

More information

Complications of Inferior Vena Caval Filters

Complications of Inferior Vena Caval Filters Complications of Inferior Vena Caval Filters Thuong G. Van Ha, M.D. 1 ABSTRACT Inferior vena caval filters have been shown to be effective in the prevention of pulmonary embolism, with low morbidity and

More information

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section. TITLE VENOUS THROMBOEMBOLISM PROPHYLAXIS SCOPE Provincial Acute and Sub-Acute Care Facilities APPROVAL AUTHORITY Alberta Health Services Executive Committee SPONSOR Vice President, Quality and Chief Medical

More information

Suprarenal Inferior Vena Cava Filters: A 20-Year Single-Center Experience

Suprarenal Inferior Vena Cava Filters: A 20-Year Single-Center Experience Suprarenal Inferior Vena Cava Filters: A 20-Year Single-Center Experience 1 Sanjeeva P. Kalva, MD, Chrysanthi Chlapoutaki, MD, Stephan Wicky, MD, Alan J. Greenfield, MD, Arthur C. Waltman, MD, and Christos

More information

Meissner MH, Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, et al. J Vasc Surg. 2012;55:

Meissner MH, Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, et al. J Vasc Surg. 2012;55: Early thrombus removal strategies for acute deep venous thrombosis: Clinical Practice Guidelines of the Society for Vascular Surgery and the American Venous Forum Meissner MH, Gloviczki P, Comerota AJ,

More information

Updates in venous thromboembolism. Cecilia Becattini University of Perugia

Updates in venous thromboembolism. Cecilia Becattini University of Perugia Updates in venous thromboembolism Cecilia Becattini University of Perugia News for VTE Diagnosis Treatment the acute phase the agents Pulmonary embolism: diagnosis Vein ultrasonography Meta-analysis 15

More information

Dr. Steve Ligertwood Dr. Roderick Tukker Dr. David Wilton

Dr. Steve Ligertwood Dr. Roderick Tukker Dr. David Wilton Dr. Steve Ligertwood Hospitalist Royal Columbian Hospital Regional Department Head-Hospitalist for Fraser Health Authority Project Lead BC Hospitalist VTE Collaborative Clinical Instructor, UBC School

More information

Medical Patients: A Population at Risk

Medical Patients: A Population at Risk Case Vignette A 68-year-old woman with obesity was admitted to the Medical Service with COPD and pneumonia and was treated with oral corticosteroids, bronchodilators, and antibiotics. She responded well

More information

Venous Thromboembolism National Hospital Inpatient Quality Measures

Venous Thromboembolism National Hospital Inpatient Quality Measures Venous Thromboembolism National Hospital Inpatient Quality Measures Presentation Overview Review venous thromboembolism as a new mandatory measure set Outline measures with exclusions and documentation

More information

Management of Cancer Associated Thrombosis (CAT) where data is lacking. Tim Nokes Haematologist, Derriford Hospital, Plymouth

Management of Cancer Associated Thrombosis (CAT) where data is lacking. Tim Nokes Haematologist, Derriford Hospital, Plymouth Management of Cancer Associated Thrombosis (CAT) where data is lacking Tim Nokes Haematologist, Derriford Hospital, Plymouth Contents Overview of the statistics and aetiology for Cancer Associated Thrombosis

More information

SAFETY AND EFFECTIVENESS OF INFERIOR VENA CAVA FILTERS USED TO PROTECT AGAINST PULMONARY EMBOLUS

SAFETY AND EFFECTIVENESS OF INFERIOR VENA CAVA FILTERS USED TO PROTECT AGAINST PULMONARY EMBOLUS TITLE: SAFETY AND EFFECTIVENESS OF INFERIOR VENA CAVA FILTERS USED TO PROTECT AGAINST PULMONARY EMBOLUS AUTHOR: Judith Walsh, MD, MPH Professor of Medicine Division of General Internal Medicine Department

More information

Venous Thrombo-Embolism. John de Vos Consultant Haematologist RSCH

Venous Thrombo-Embolism. John de Vos Consultant Haematologist RSCH Venous Thrombo-Embolism John de Vos Consultant Haematologist RSCH overview The statistics Pathogenesis Prophylaxis Treatment Agent Duration Incidental VTE Recurrence of VTE IVC filters CVC related thrombosis

More information

Deep vein thrombosis and its prevention in critically ill adults Attia J, Ray J G, Cook D J, Douketis J, Ginsberg J S, Geerts W H

Deep vein thrombosis and its prevention in critically ill adults Attia J, Ray J G, Cook D J, Douketis J, Ginsberg J S, Geerts W H Deep vein thrombosis and its prevention in critically ill adults Attia J, Ray J G, Cook D J, Douketis J, Ginsberg J S, Geerts W H Authors' objectives To systematically review the incidence of deep vein

More information

Inferior Vena Cava Filter for DVT

Inferior Vena Cava Filter for DVT Inferior Vena Cava Filter for DVT Deep Vein Thrombosis A deep vein thrombosis (DVT) is a blood clot that forms in a deep vein. This is a serious condition that occurs more often than you might think. If

More information

STRUT PERFORATION OF INFERIOR VENA CAVA FILTERS. Robert Herbert. Department of Mechanical Engineering. The Ohio State University.

STRUT PERFORATION OF INFERIOR VENA CAVA FILTERS. Robert Herbert. Department of Mechanical Engineering. The Ohio State University. STRUT PERFORATION OF INFERIOR VENA CAVA FILTERS Robert Herbert Department of Mechanical Engineering The Ohio State University 2016 Thesis Committee: Dr. Samir Ghadiali, Advisor Dr. Joshua Dowell Presented

More information

A PILOT STUDY ON THE RANDOMIZATION OF INFERIOR VENA CAVA FILTER PLACEMENT FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS IN HIGH-RISK TRAUMA PATIENTS

A PILOT STUDY ON THE RANDOMIZATION OF INFERIOR VENA CAVA FILTER PLACEMENT FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS IN HIGH-RISK TRAUMA PATIENTS A PILOT STUDY ON THE RANDOMIZATION OF INFERIOR VENA CAVA FILTER PLACEMENT FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS IN HIGH-RISK TRAUMA PATIENTS By ANITA RAJASEKHAR A THESIS PRESENTED TO THE GRADUATE SCHOOL

More information

Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine

Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine Venous thromboembolism: pulmonary embolism (PE) deep vein thrombosis (DVT) 1% of all patients admitted to hospital 5% of in-hospital mortality

More information

Prevention of Venous Thromboembolism

Prevention of Venous Thromboembolism Prevention of Venous Thromboembolism Surgical Care Improvement Project Dale W. Bratzler, DO, MPH President and CEO Dale W. Bratzler, DO, MPH Oklahoma Foundation for Medical Quality QIOSC Medical Director

More information

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM International Consensus Statement 2013 Guidelines According to Scientific Evidence Developed under the auspices of the: Cardiovascular Disease Educational

More information

DEEP VEIN THROMBOSIS (DVT): TREATMENT

DEEP VEIN THROMBOSIS (DVT): TREATMENT DEEP VEIN THROMBOSIS (DVT): TREATMENT OBJECTIVE: To provide an evidence-based approach to treatment of patients presenting with deep vein thrombosis (DVT). BACKGROUND: An estimated 45,000 patients in Canada

More information